Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine hydrochloride|DRUG: pegylated liposomal doxorubicin hydrochloride
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)